Alkermes plc: Independent Proxy Advisory Firm Glass Lewis Recommends Alkermes Shareholders Vote FOR All Seven of the Company's Highly Qualified Director Nominees finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
Proxy advisory firm Institutional Investor Services urged Alkermes (ALKS.O) shareholders to elect one of three director candidates proposed by activist hedge fund Sarissa Capital, arguing more outside.
ALKS, $31.48, Market Capitalization: $5.2 billion), a fully-integrated, global biopharmaceutical company developing innovative medicines in the fields of neuroscience .
/PRNewswire/ Alkermes plc (Nasdaq: ALKS) (the Company) today issued a letter to its shareholders in connection with the Company s upcoming 2023 Annual.